Diversity of genome profiles in malignant lymphoma.
Characteristic chromosome translocations are associated with specific disease entities, and are known to play a pivotal role in lymphoma development. Chromosome translocation alone, however, is not sufficient to produce tumors. Factors including the microenvironment and epigenetic and genetic alterations other than chromosome translocations have been shown to play a role in lymphoma development. Follicular lymphoma cells proliferate in close contact with follicular dendritic cells. Mucosa-associated lymphoid tissue (MALT) lymphoma cells proliferate at the marginal zone area of reactive follicles which are formed by preceding chronic inflammation. The importance of genetic alterations other than chromosome translocation has been recognized since the introduction of array comparative genomic hybridization (array CGH). Variations in the genomic profile among patients with the same disease entity have been found by array CGH analyses. These variations indicate that multiple genetic pathways leading to the development of lymphomas may exist and hence result in the variable clinicopathological features observed.
Seto
Masao
M
Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan. mseto@aichi-cc.jp
Honma
Keiichiro
K
Nakagawa
Masao
M
D000818:Animals; D019254:Genes, bcl-2; D014644:Genetic Variation; D006801:Humans; D007143:Immunoglobulin Heavy Chains / Q000235:genetics; D008223:Lymphoma / Q000209:etiology / Q000235:genetics*; D014178:Translocation, Genetic
D007143:Immunoglobulin Heavy Chains